Why the study?
Does oral trientine improve cardiac structure and reduce left ventricular mass in diabetes-associated heart disease?
Does oral trientine improve cardiac structure and reduce left ventricular mass in diabetes-associated heart disease?
Selective copper chelation with trientine may reverse cardiac damage and reduce left ventricular mass in diabetes-associated heart disease.
No takes yet. Share an insight, caveat, or question.
Hypothesis-generating for trientine in diabetic cardiomyopathy; randomized trials required before clinical consideration.
Cooper et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: